Collectively, these results demonstratethat integrating GOx-DOX-LGP with PD-1 checkpoint inhibition effectivelymodulates the tumor immune landscape and promotes synergistic antitumoractivity in HCC. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.